RNAZ - Transcode Therapeutics, Inc.
9.6
0.270 2.813%
Share volume: 11,532
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$9.33
0.27
0.03%
View ratios
| Fiscal Date | 06-30-2024 | 09-30-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2024 | Q3 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 08-14-2024 | 11-14-2024 | 05-14-2025 | 11-14-2025 | |
| Cash flow financing | 0.000 | 2.447 M | 8.855 M | -455.726 K | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | 0.000 | -1.479 M | 5.758 M | 0.000 | |
| Net income | -5.191 M | -2.321 M | -12.085 M | -4.856 M | |
| Depreciation | 0.000 | 16.031 K | 13.443 K | 4.781 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 0.000 | -12.870 K | 0.000 | 0.000 | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 12.870 K | 0.000 | 0.000 | |
| Cash Change | 0.000 | -1.479 M | 5.758 M | -4.539 M |